Cyclobenzaprine - ALZA Corporation

Drug Profile

Cyclobenzaprine - ALZA Corporation

Alternative Names: Flexeril; Flexeril XL; MK-130; OROS Cyclobenzaprine

Latest Information Update: 02 Aug 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator ALZA Corporation
  • Class Dibenzocycloheptenes; Muscle relaxants; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Musculoskeletal pain; Spasm

Most Recent Events

  • 30 Jul 2010 Generic equivalent available in USA for Spasm
  • 30 Oct 2003 Data from a media release have been added to the adverse events and Musculoskeletal Disorders therapeutic trials sections
  • 25 Jun 2003 Data from a media release have been added to the Musculoskeletal pain therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top